Rachel Geman, a partner in the New York office, combats frauds that harm her clients in their lives and misconduct that threatens the fairness and safety of their workplaces and communities.
Recent successes and exemplar ongoing matters:
- Named Co-Lead Counsel for the Medical Monitoring Class in the Valsartan contaminated drug litigation (2023)
- Counsel for the whistleblower in litigation against AbbVie involving the marketing of Humira ($27 million in settlements as of 2023)
- Co-Lead Counsel in consumer privacy litigation against fintech company Plaid (2022 settlement of $58 million and robust injunctive relief)
- Lead Counsel for whistleblowers in matter involving fraud in New York’s Indigent Care Program against the Door (2022 settlement of $12.9 million)
- Represented consumers in the GM Ignition Switch MDL economic loss litigation (2020 settlement of $121 million)
- Co-Lead Counsel representing the City of Philadelphia in Fair Housing Act litigation against Wells Fargo (2019 settlement with the bank’s funding city programs for communities affected by lending discrimination and agreeing to other relief)
- Exemplar earlier cases: Rachel was co-lead class counsel or counsel for the class in consumer financial litigation over “payment protection” products, resulting in more than $50 million in settlements; she represented employee benefit plans in recovering $65 million from AXA Rosenberg; she represented a class of female financial advisors who secured $39 million plus injunctive relief from Bank of America/Merrill Lynch to settle gender discrimination claims; and she cut her teeth in the False Claims Act years ago in helping to recoup $78.5 million from the University of Phoenix in one of the largest settlements involving fraud on the Department of Education.
Rachel leads the firm’s whistleblower practice group; serves as the employee-side chair of the ABA’s Workplace and Occupational Safety and Health Law Committee; and is a CDRC-trained community mediator.